Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study-Reference-Cited by-同舟云学术

Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study

Published:2019-07-25 Issue:6 Volume:181 Page:1177-1189
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Thaçi D.¹,Papp K.²^ORCID,Marcoux D.³,Weibel L.⁴,Pinter A.⁵,Ghislain P.‐D.⁶,Landells I.⁷,Hoeger P.H.⁸^ORCID,Unnebrink K.⁹,Seyger M.M.B.¹⁰,Williams D.A.¹¹,Rubant S.⁹,Philipp S.¹²

Affiliation:

1. Institute and Comprehensive Center for Inflammation Medicine University of Lübeck Ratzeburger Allee 160 23435 Lübeck Germany

2. K Papp Clinical Research and Probity Medical Research University of Western Ontario Waterloo ON Canada

3. CHU Sainte‐Justine Montreal Montreal QC Canada

4. Pediatric Dermatology Department University Children's Hospital Zurich, and Dermatology Department University Hospital Zurich Zurich Switzerland

5. University Clinic of Frankfurt am Main, Department of Dermatology, Venereology and Allergology Frankfurt am Main Germany

6. UCL St Luc Brussels Belgium

7. Nexus Clinical Research and Memorial University of Newfoundland St John's NL Canada

8. Department of Pediatric Dermatology Catholic Children's Hospital Hamburg Germany

9. AbbVie Deutschland GmbH & Co. KG Ludwigshafen Germany

10. Department of Dermatology and Radboud Institute for Health Sciences Radboud University Medical Center Nijmegen the Netherlands

11. AbbVie Inc. North Chicago IL U.S.A.

12. Department of Dermatology, Venerology and Allergy Charité Universitätsmedizin Berlin Berlin Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.18029

Reference45 articles.

1. World Health Organization.Global Report on Psoriasis 2016. Available at:http://www.who.int/iris/handle/10665/204417(last accessed 3 June 2019).

2. The epidemiology of childhood psoriasis: a scoping review

3. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases

4. Determinants of quality of life in patients with psoriasis: A study from the US population

5. The influence of treatments in daily clinical practice on the Children’s Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of adalimumab with methotrexate for psoriasis: A meta-analysis of randomized controlled studies;Medicine;2024-08-09

2. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis;Dermatologic Clinics;2024-07

3. How can we optimize the use of methotrexate to treat pediatric patients with inflammatory skin diseases?;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03

4. Epidemiology, comorbidity, and use of systemic therapies in patients with paediatric psoriasis in Germany;Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen;2023-12

5. Biological therapies for the treatment of psoriasis in pediatrics;Expert Opinion on Biological Therapy;2023-11-10